ClinicalTrials.Veeva

Menu

Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement

G

German Heart Center Munich

Status

Enrolling

Conditions

AV Block Complete
Tricuspid Regurgitation (TR)

Study type

Observational

Funder types

Other

Identifiers

NCT06814574
GER-EP-26

Details and patient eligibility

About

Transcatheter tricuspid valve replacement (TTVR) is associated with a high risk of third-degree atrioventricular block (AVB). However, the optimal pacemaker management following TTVR remains unclear. This study aims to identify an optimal therapeutic approach for pacemaker implantation in patients undergoing TTVR.

Enrollment

25 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Transcatheter Tricuspid Valve Replacement

Exclusion criteria

  • no defined exclusion criteria

Trial contacts and locations

1

Loading...

Central trial contact

Carsten Lennerz, PD Dr. med.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems